GAVIN LOVE ORTHOPAEDICS LTDActive

Company number SC713515Private limited companyIncorporated 2021

Key figures

£265,330+26.9%
Net assets 2024/25
+39.4%
Average annual growth 2021/22–2024/25
0100 k200 k300 k2021/222022/232023/242024/25

Like most small UK companies, GAVIN LOVE ORTHOPAEDICS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2021/222022/232023/242024/25
Filed accounts2021/22–2024/25
2021/222022/232023/242024/25
Total assets113,582163,557235,837294,367
Total liabilities14,33921,80625,10527,382
Net assets / total equity97,943140,606209,157265,330
Average number of employees1233

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the company during the year under review was specialsit medical consultancy.

As described in the company's latest filed accounts.

Summary: GAVIN LOVE ORTHOPAEDICS LTD

Company

GAVIN LOVE ORTHOPAEDICS LTD is a private limited company registered with Companies House under company number SC713515. It was incorporated on 28 Oct 2021. Its status is active. The registered office is in Cupar (KY15). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files micro-entity accounts. Net assets were £265,330, up 26.9% on the previous year. Total assets were £294,367 and total liabilities £27,382. The company had an average of 3 employees. Figures are available for 4 financial years (2021/22–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 10 Nov 2026.